Ledger.Open graph →
SEC Form D · filed June 13, 2019

Comet Therapeutics, Inc

Offering
$14.1M
Sold
$14.1M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Bernardus Machielse · CAMBRIDGE, MADirectorEnej Kuscer, Ph.D · CAMBRIDGE, MAExecPeter Van Vlasselaer, Ph.D · CAMBRIDGE, MADirectorHenrijette Richter, Ph.D · CAMBRIDGE, MADirectorLucas De Breed · CAMBRIDGE, MADirectorDavid De Graaf, Ph.D · NEW YORK, NYExec · DirectorArt Taveras, Ph.D · CAMBRIDGE, MAExecEnej Kuscer, Ph.D · CAMBRIDGE, MAExecPeter Van Vlasselaer, Ph.D · CAMBRIDGE, MADirectorHenrijette Richter, Ph.D · CAMBRIDGE, MADirectorBernardus Machielse · Princeton, NJDirectorLucas De Breed · CAMBRIDGE, MADirectorDavid De Graaf, Ph.D · NEW YORK, NYExec · DirectorArt Taveras, Ph.D · CAMBRIDGE, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗